Concepedia

Author

Gary F. Breen

GlaxoSmithKline (United Kingdom)

Also Known As

G. F. BREEN, Gary Breen, Gary F Breen, Gary F. Breen

10

Publications

201

Citations

6

H-Index

15

Concepts

All Affiliations

GlaxoSmithKline (United Kingdom)
GF

About

Gary F. Breen is an author at GlaxoSmithKline (United Kingdom) specializing in biomolecular engineering, pharmacology, and natural sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Biomolecular Engineering

4

4

121

2

Medicine

3

3

74

3

Natural Sciences

3

3

94

4

Biochemistry

3

3

94

5

Engineering

2

2

56

Gary F. Breen

×

6

Publications

199

Citations

6

H-Index

YearCitations

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 2:  Conversion of the Key Intermediate SB-235349 to SB-214857-A

Richard J. Atkins, Adam Banks, Richard K. Bellingham,

Organic Process Research & Development

2003

49

Enzymatic resolution of a secondary amine using novel acylating reagents

Gary F. Breen

Tetrahedron Asymmetry

2004

47

A new synthesis of the GPIIb/IIIa receptor antagonist SB-214857-A

Ian P. Andrews, Richard J. Atkins, Neil F. Badham,

Tetrahedron Letters

2001

29

Synthetic Routes to Quinoline Derivatives:  Novel Syntheses of 3-Butyryl-8-methoxy-4-[(2-methylphenyl)amino]quinoline and 3-Butyryl-8-(2-hydroxyethoxy)-4-[(2-methylphenyl)amino]quinoline

Richard J. Atkins, Gary F. Breen, Lynne P. Crawford,

Organic Process Research & Development

1997

29

Process Development and Scale Up of a Glycine Antagonist

Adam Banks, Gary F. Breen, Darren Caine,

Organic Process Research & Development

2009

27

The Development of a Manufacturing Route for the GPIIb/IIIa Receptor Antagonist SB-214857-A. Part 1:  Synthesis of the Key Intermediate 2,3,4,5-Tetrahydro-4-methyl-3-oxo-1<i>H</i>-1,4-benzodiazepine-2-acetic Acid Methyl Ester, SB-235349

Ian P. Andrews, Richard J. Atkins, Gary F. Breen,

Organic Process Research & Development

2003

18

Page 1